This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Radiation Therapy  • Liver/ Biliary Tract/ Pancreatic Diseases  • Alert me on articles by topic

Christian Herfarth, MD
Heidelberg, Germany

Arch Surg. 2000;135:88.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A prospective uncontrolled study on preoperative chemoradiotherapy in patients with locally advanced pancreatic cancer is presented. The neoadjuvant therapeutic regimen consisted of fluorouracil, 400 mg/m², and cisplatin, 25 mg/m², along with concurrent radiation of 45 Gy. Patients were surgically staged prior to the neoadjuvant regimen and had biliary along with gastric bypass as well as a feeding jejunostomy tube placed. Of 14 patients, 11 underwent reexploration. Two of these 11 patients had progressive disease that was unresectable; 9 had definitive resections, 6 of whom had either portal vein or major arterial resections. There was 1 hospital death and 1 long-term survivor (>96 months). Median survival was 16 months after definitive surgery.

Although this study represents another valuable effort to improve the prognosis of patients with pancreatic cancer, even after potentially curative resection, a number of concerns remain. It is stated that only patients with locally . . . [Full Text of this Article]

RELATED ARTICLE

Preoperative Chemotherapy, Radiotherapy, and Surgical Resection of Locally Advanced Pancreatic Cancer
Harold J. Wanebo, Arvin S. Glicksman, Michael P. Vezeridis, Jeffrey Clark, Lawrence Tibbetts, R. James Koness, and Audrey Levy
Arch Surg. 2000;135(1):81-87.
ABSTRACT | FULL TEXT